Insider Transactions in Q4 2025 at Mbx Biosciences, Inc. (MBX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 24
2025
|
P. Kent Hawryluk President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
182,859
+21.59%
|
$548,577
$3.25 P/Share
|
|
Oct 20
2025
|
P. Kent Hawryluk President & CEO |
BUY
Open market or private purchase
|
Indirect |
20,000
+4.1%
|
$260,000
$13.64 P/Share
|
|
Oct 17
2025
|
Steven L. Hoerter |
BUY
Open market or private purchase
|
Indirect |
20,000
+50.0%
|
$260,000
$13.25 P/Share
|